(Q74587591)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9600682%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

title

Ability to remove immunoglobulins and anti-ganglioside antibodies by plasma exchange, double-filtration plasmapheresis and immunoadsorption (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9600682%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

2

N Yuki

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9600682%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

author name string

Y Tagawa

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9600682%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

K Hirata

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9600682%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

publication date

1 April 1998

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9600682%20AND%20SRC:MED&resulttype=core&format=json

Journal of the Neurological Sciences

11 November 2019

number of pages

6

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9600682%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

volume

157

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9600682%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9600682%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

page(s)

90-95

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9600682%20AND%20SRC:MED&resulttype=core&format=json

Acute conduction block in vitro following exposure to antiganglioside sera.

11 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2898%2900067-7

Assessment of current diagnostic criteria for Guillain-Barré syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2898%2900067-7

Lipopolysaccharides of Campylobacter jejuni serotype O:19: structures of core oligosaccharide regions from the serostrain and two bacterial isolates from patients with the Guillain-Barré syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2898%2900067-7

Interleukins. Clinical pharmacokinetics and practical implications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2898%2900067-7

Serum anti-GQ1b IgG antibody is associated with ophthalmoplegia in Miller Fisher syndrome and Guillain-Barré syndrome: clinical and immunohistochemical studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2898%2900067-7

Efficiency of plasma exchange in Guillain-Barré syndrome: role of replacement fluids. French Cooperative Group on Plasma Exchange in Guillain-Barré syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2898%2900067-7

Plasma exchange in Guillain-Barré syndrome: one-year follow-up. French Cooperative Group on Plasma Exchange in Guillain-Barré Syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2898%2900067-7

Serum interleukin-2 concentrations in Guillain-Barré syndrome and chronic idiopathic demyelinating polyradiculoneuropathy: comparison with other neurological diseases of presumed immunopathogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2898%2900067-7

Acute axonal Guillain-Barré syndrome with IgG antibodies against motor axons following parenteral gangliosides

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2898%2900067-7

Coagulation Abnormalities Produced by Plasma Exchange on the Cell Separator with Special Reference to Fibrinogen and Platelet Levels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2898%2900067-7

The clinical correlates of high-titer IgG anti-GM1 antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2898%2900067-7

Guillain-Barré syndrome after exogenous gangliosides in Italy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2898%2900067-7

Plasmapheresis: technique and complications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2898%2900067-7

Experimental conduction block induced by serum from a patient with anti-GM1 antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2898%2900067-7

Antibodies against GM1 ganglioside affect K+ and Na+ currents in isolated rat myelinated nerve fibers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2898%2900067-7

Appropriate number of plasma exchanges in Guillain-Barré syndrome. The French Cooperative Group on Plasma Exchange in Guillain-Barré Syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2898%2900067-7

Plasma exchange and intravenous immunoglobulin treatment of neuromuscular disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2898%2900067-7

A randomized trial comparing intravenous immune globulin and plasma exchange in Guillain-Barré syndrome. Dutch Guillain-Barré Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2898%2900067-7

Guillain-Barré syndrome without sensory loss (acute motor neuropathy). A subgroup with specific clinical, electrodiagnostic and laboratory features. Dutch Guillain-Barré Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2898%2900067-7

Association between glycoconjugate antibodies and Campylobacter infection in patients with Guillain-Barré syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2898%2900067-7

Monoclonal IgM antibodies to GM1 and asialo-GM1 in chronic neuropathies cross-react with Campylobacter jejuni lipopolysaccharides

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2898%2900067-7

The effect of serial therapeutic plasmapheresis on platelet count, coagulation factors, plasma immunoglobulin, and complement levels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2898%2900067-7

A bacterium lipopolysaccharide that elicits Guillain-Barré syndrome has a GM1 ganglioside-like structure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2898%2900067-7

Tryptophan-immobilized column adsorbs immunoglobulin G anti-GQ1b antibody from Fisher's syndrome: A new approach to treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2898%2900067-7

Close association of Guillain-Barré syndrome with antibodies to minor monosialogangliosides GM1b and GM1 alpha

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2898%2900067-7

Immunoglobulin A (IgA): molecular and cellular interactions involved in IgA biosynthesis and immune response.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2898%2900067-7

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0022-510X(98)00067-7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9600682%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

1 reference